\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	physical\\ examination\\ revealed\\ a\\ healthy\\ appearing\\ female\\ in\\ no\\ apparent\\ distress\\.\\ examination\\ of\\ the\\ lower\\ legs\\ revealed\\ large\\,\\ discrete\\,\\ irregularly\\ shaped\\ yellow\\ to\\ erythematous\\ plaques\\ on\\ the\\ anterior\\ and\\ medial\\ aspect\\ of\\ both\\ lower\\ legs\\.\\ the\\ plaques\\ were\\ markedly\\ indurated\\ and\\ covered\\ with\\ numerous\\ prominent\\ telangiectasias\\.\\ there\\ was\\ a\\ small\\ area\\ of\\ necrosis\\ with\\ focal\\ ulceration\\ on\\ the\\ inferior\\ aspect\\ of\\ the\\ lesion\\ on\\ the\\ left\\ leg\\.\\ there\\ was\\ no\\ palpable\\ regional\\ lymphadenopathy\\.\ \(0\)\
\-\ an\\ incisional\\ biopsy\\ was\\ performed\\ revealing\\ numerous\\ microcystic\\ spaces\\ in\\ the\\ deep\\ dermis\\ and\\ subcutaneous\\ fat\\ with\\ foreign\\ body\\ granulomatous\\ reaction\\,\\ foamy\\ histiocytic\\ infiltration\\,\\ stromal\\ hyalinization\\,\\ and\\ microcalcification\\ with\\ overlying\\ ulceration\\ consistent\\ with\\ silicone\\ granulomata\\.\ \(0\)\
\-\ the\\ patient\\ subsequently\\ underwent\\ excision\\ of\\ the\\ entire\\ lesion\\ on\\ the\\ left\\ lower\\ leg\\ with\\ placement\\ of\\ a\\ myocutaneous\\ free\\-flap\\ composed\\ of\\ latissimus\\ dorsi\\ and\\ split\\-thickness\\ skin\\ grafts\\.\\ she\\ tolerated\\ the\\ procedure\\ well\\ and\\ is\\ recovering\\ nicely\\.\ \(0\)\
\-\ silicone\\ granuloma\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#6\\)\\ presented\\ by\\:\\ lcdr\\ william\\ f\\.\\ smith\\,\\ mc\\,\\ usnr\ \(0\)\
\-\ the\\ patient\\ underwent\\ silicone\\ injections\\ of\\ both\\ lower\\ legs\\ in\\ the\\ early\\ 1960\\'s\\.\\ approximately\\ twenty\\ years\\ later\\ she\\ noted\\ progressive\\ scaling\\ and\\ erythema\\ in\\ the\\ injected\\ area\\,\\ and\\ subsequently\\ developed\\ firm\\,\\ slowly\\ enlarging\\ plaques\\ on\\ the\\ anterior\\ and\\ medial\\ aspect\\ of\\ both\\ lower\\ legs\\.\\ she\\ also\\ reported\\ pain\\ of\\ the\\ left\\ lower\\ extremity\\ with\\ ambulation\\.\\ pmhx\\:\\ significant\\ for\\ hypertension\\,\\ for\\ which\\ she\\ takes\\ zestril\\ 20\\ mg\\ per\\ day\\.\\ she\\ has\\ smoked\\ 1\\-2\\ ppd\\ of\\ cigarettes\\ for\\ greater\\ than\\ 30\\ years\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ legs\\:\\ 0\\.06728528991912833\ \(0\)\
\-\ silicone\\:\\ 0\\.060626420573945634\ \(0\)\
\-\ plaques\\:\\ 0\\.05206327806689398\ \(0\)\
\-\ she\\:\\ 0\\.043614293480984945\ \(0\)\
\-\ lower\\:\\ 0\\.04193153605884792\ \(0\)\
\-\ ulceration\\:\\ 0\\.03825578445437879\ \(0\)\
\-\ hyalinization\\:\\ 0\\.03205643063260545\ \(0\)\
\-\ free\\-flap\\:\\ 0\\.03205643063260545\ \(0\)\
\-\ split\\-thickness\\:\\ 0\\.03205643063260545\ \(0\)\
\-\ zestril\\:\\ 0\\.03205643063260545\ \(0\)\
\-\ myocutaneous\\:\\ 0\\.029535895430569285\ \(0\)\
\-\ 1960\\:\\ 0\\.029535895430569285\ \(0\)\
\-\ scaling\\:\\ 0\\.029535895430569285\ \(0\)\
\-\ aspect\\:\\ 0\\.029283184739818446\ \(0\)\
\-\ subsequently\\:\\ 0\\.028173643646234137\ \(0\)\
\-\ histiocytic\\:\\ 0\\.028061476855630502\ \(0\)\
\-\ numerous\\:\\ 0\\.027868449470968452\ \(0\)\
\-\ telangiectasias\\:\\ 0\\.027015360228533118\ \(0\)\
\-\ foamy\\:\\ 0\\.027015360228533118\ \(0\)\
\-\ microcalcification\\:\\ 0\\.027015360228533118\ \(0\)\
\-\ granulomata\\:\\ 0\\.027015360228533118\ \(0\)\
\-\ latissimus\\:\\ 0\\.026203929132845083\ \(0\)\
\-\ dorsi\\:\\ 0\\.026203929132845083\ \(0\)\
\-\ william\\:\\ 0\\.02554094165359434\ \(0\)\
\-\ incisional\\:\\ 0\\.024980393726949764\ \(0\)\
\-\ lcdr\\:\\ 0\\.024980393726949764\ \(0\)\
\-\ usnr\\:\\ 0\\.024980393726949764\ \(0\)\
\-\ cigarettes\\:\\ 0\\.024494825026496952\ \(0\)\
\-\ leg\\:\\ 0\\.024437798608063974\ \(0\)\
\-\ both\\:\\ 0\\.023805818080212236\ \(0\)\
\-\ smoked\\:\\ 0\\.023683393930808917\ \(0\)\
\-\ microcystic\\:\\ 0\\.02333681145879319\ \(0\)\
\-\ grafts\\:\\ 0\\.02333681145879319\ \(0\)\
\-\ indurated\\:\\ 0\\.023020406451558173\ \(0\)\
\-\ recovering\\:\\ 0\\.022208975355870138\ \(0\)\
\-\ twenty\\:\\ 0\\.021545987876619394\ \(0\)\
\-\ underwent\\:\\ 0\\.021325062076205232\ \(0\)\
\-\ covered\\:\\ 0\\.02098543994997482\ \(0\)\
\-\ nicely\\:\\ 0\\.02098543994997482\ \(0\)\
\-\ ambulation\\:\\ 0\\.02098543994997482\ \(0\)\
\-\ irregularly\\:\\ 0\\.020208806857981876\ \(0\)\
\-\ f\\.\\:\\ 0\\.020208806857981876\ \(0\)\
\-\ ppd\\:\\ 0\\.020208806857981876\ \(0\)\
\-\ yellow\\:\\ 0\\.020071569301680615\ \(0\)\
\-\ revealing\\:\\ 0\\.020071569301680615\ \(0\)\
\-\ revealed\\:\\ 0\\.019945264653571586\ \(0\)\
\-\ dermis\\:\\ 0\\.01993932332287743\ \(0\)\
\-\ medial\\:\\ 0\\.01987854191701856\ \(0\)\
\-\ regional\\:\\ 0\\.01968844015383397\ \(0\)\
\-\ area\\:\\ 0\\.019649718139158306\ \(0\)\
\-\ tolerated\\:\\ 0\\.019569204434477645\ \(0\)\
\-\ stromal\\:\\ 0\\.019341857681818245\ \(0\)\
\-\ injections\\:\\ 0\\.019341857681818245\ \(0\)\
\-\ examination\\:\\ 0\\.01931944025799684\ \(0\)\
\-\ injected\\:\\ 0\\.019233301452183042\ \(0\)\
\-\ composed\\:\\ 0\\.01902545267458323\ \(0\)\
\-\ takes\\:\\ 0\\.01902545267458323\ \(0\)\
\-\ pmhx\\:\\ 0\\.018379339302810674\ \(0\)\
\-\ years\\:\\ 0\\.018249040996498055\ \(0\)\
\-\ mc\\:\\ 0\\.018214021578895196\ \(0\)\
\-\ erythematous\\:\\ 0\\.018055893899114328\ \(0\)\
\-\ discrete\\:\\ 0\\.017904356821294078\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.017830892431048552\ \(0\)\
\-\ 1997\\:\\ 0\\.01741878812084127\ \(0\)\
\-\ seminar\\:\\ 0\\.01729118332152756\ \(0\)\
\-\ smith\\:\\ 0\\.01729118332152756\ \(0\)\
\-\ uniformed\\:\\ 0\\.01710779839924795\ \(0\)\
\-\ mg\\:\\ 0\\.017048669232441478\ \(0\)\
\-\ infiltration\\:\\ 0\\.01693321942038846\ \(0\)\
\-\ slowly\\:\\ 0\\.016876840560257674\ \(0\)\
\-\ services\\:\\ 0\\.016766639289365573\ \(0\)\
\-\ dermatology\\:\\ 0\\.016766639289365573\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.01616752935090719\ \(0\)\
\-\ anterior\\:\\ 0\\.016005765991001727\ \(0\)\
\-\ shaped\\:\\ 0\\.01581676474658878\ \(0\)\
\-\ enlarging\\:\\ 0\\.01581676474658878\ \(0\)\
\-\ spaces\\:\\ 0\\.015310357229012387\ \(0\)\
\-\ foreign\\:\\ 0\\.015310357229012387\ \(0\)\
\-\ entire\\:\\ 0\\.01527417420772814\ \(0\)\
\-\ granuloma\\:\\ 0\\.01527417420772814\ \(0\)\
\-\ erythema\\:\\ 0\\.01527417420772814\ \(0\)\
\-\ physical\\:\\ 0\\.015247311051499915\ \(0\)\
\-\ firm\\:\\ 0\\.015238347675208097\ \(0\)\
\-\ granulomatous\\:\\ 0\\.014996983788135836\ \(0\)\
\-\ markedly\\:\\ 0\\.014708486543639394\ \(0\)\
\-\ reaction\\:\\ 0\\.014112889057584751\ \(0\)\
\-\ overlying\\:\\ 0\\.014060940122139381\ \(0\)\
\-\ healthy\\:\\ 0\\.014009722886205785\ \(0\)\
\-\ appearing\\:\\ 0\\.013811776680551177\ \(0\)\
\-\ apparent\\:\\ 0\\.013740239351101342\ \(0\)\
\-\ per\\:\\ 0\\.01360125312266426\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.013213581358816048\ \(0\)\
\-\ on\\:\\ 0\\.01316165477028051\ \(0\)\
\-\ distress\\:\\ 0\\.013093027877663681\ \(0\)\
\-\ procedure\\:\\ 0\\.013014823495041997\ \(0\)\
\-\ prominent\\:\\ 0\\.012753639005691975\ \(0\)\
\-\ excision\\:\\ 0\\.012753639005691975\ \(0\)\
\-\ lesion\\:\\ 0\\.012658583461821488\ \(0\)\
\-\ placement\\:\\ 0\\.012612403248178288\ \(0\)\
\-\ deep\\:\\ 0\\.012577935088343584\ \(0\)\
\-\ \\:\\:\\ 0\\.012330270719898164\ \(0\)\
\-\ progressive\\:\\ 0\\.012281596781975646\ \(0\)\
\-\ necrosis\\:\\ 0\\.012265820776162562\ \(0\)\
\-\ hypertension\\:\\ 0\\.012250112917455229\ \(0\)\
\-\ \\#\\:\\ 0\\.01218795134160323\ \(0\)\
\-\ developed\\:\\ 0\\.011963874490308052\ \(0\)\
\-\ 30\\:\\ 0\\.011949415768927545\ \(0\)\
\-\ skin\\:\\ 0\\.01193501430995992\ \(0\)\
\-\ greater\\:\\ 0\\.011671695846074548\ \(0\)\
\-\ early\\:\\ 0\\.01136421443506341\ \(0\)\
\-\ extremity\\:\\ 0\\.01136421443506341\ \(0\)\
\-\ reported\\:\\ 0\\.01132754491118477\ \(0\)\
\-\ later\\:\\ 0\\.011219704149065177\ \(0\)\
\-\ 20\\:\\ 0\\.011172782676934603\ \(0\)\
\-\ biopsy\\:\\ 0\\.011024339060497311\ \(0\)\
\-\ palpable\\:\\ 0\\.011013167427635601\ \(0\)\
\-\ \\,\\:\\ 0\\.010828402620691496\ \(0\)\
\-\ was\\:\\ 0\\.01078120933324022\ \(0\)\
\-\ inferior\\:\\ 0\\.010542968586760229\ \(0\)\
\-\ left\\:\\ 0\\.01043023930115907\ \(0\)\
\-\ body\\:\\ 0\\.010091868046142125\ \(0\)\
\-\ day\\:\\ 0\\.00986530847037429\ \(0\)\
\-\ approximately\\:\\ 0\\.009613883005656665\ \(0\)\
\-\ fat\\:\\ 0\\.00945059026502412\ \(0\)\
\-\ 6\\:\\ 0\\.009280436950454088\ \(0\)\
\-\ there\\:\\ 0\\.009248840410654463\ \(0\)\
\-\ focal\\:\\ 0\\.008874522196866916\ \(0\)\
\-\ performed\\:\\ 0\\.008663921204462978\ \(0\)\
\-\ presented\\:\\ 0\\.008470391400081488\ \(0\)\
\-\ significant\\:\\ 0\\.008355807822015358\ \(0\)\
\-\ than\\:\\ 0\\.008141995836066451\ \(0\)\
\-\ the\\:\\ 0\\.008043594746392773\ \(0\)\
\-\ for\\:\\ 0\\.007953907076102348\ \(0\)\
\-\ consistent\\:\\ 0\\.007619266432113466\ \(0\)\
\-\ noted\\:\\ 0\\.007365167958009432\ \(0\)\
\-\ small\\:\\ 0\\.007158455579567704\ \(0\)\
\-\ were\\:\\ 0\\.007055586678872441\ \(0\)\
\-\ well\\:\\ 0\\.007029385283522367\ \(0\)\
\-\ \\'s\\:\\ 0\\.0068510786122438\ \(0\)\
\-\ exam\\:\\ 0\\.006826305236180138\ \(0\)\
\-\ case\\:\\ 0\\.006798197937699166\ \(0\)\
\-\ large\\:\\ 0\\.006794699752113017\ \(0\)\
\-\ female\\:\\ 0\\.006388219168901213\ \(0\)\
\-\ no\\:\\ 0\\.0062577756414821965\ \(0\)\
\-\ patient\\:\\ 0\\.006229759497573731\ \(0\)\
\-\ in\\:\\ 0\\.006129414256585526\ \(0\)\
\-\ also\\:\\ 0\\.006125889431527823\ \(0\)\
\-\ and\\:\\ 0\\.005891203823963513\ \(0\)\
\-\ has\\:\\ 0\\.005835272619979193\ \(0\)\
\-\ which\\:\\ 0\\.005800525771791086\ \(0\)\
\-\ by\\:\\ 0\\.0051740760117995445\ \(0\)\
\-\ of\\:\\ 0\\.004660152031919537\ \(0\)\
\-\ a\\:\\ 0\\.00432654329256656\ \(0\)\
\-\ an\\:\\ 0\\.004296963142853563\ \(0\)\
\-\ pain\\:\\ 0\\.0037949387910208533\ \(0\)\
\-\ with\\:\\ 0\\.002978288118651739\ \(0\)\
\-\ \\(\\:\\ 0\\.0026267699136140383\ \(0\)\
\-\ \\)\\:\\ 0\\.002594682516775655\ \(0\)\
\-\ is\\:\\ 0\\.0020446937395808204\ \(0\)\
\-\ \\.\\:\\ 0\\.0016781598882381875\ \(0\)\
\-\ to\\:\\ 0\\.0015529749397926772\ \(0\)\
